Extendicare (TSE:EXE – Get Free Report) was upgraded by investment analysts at Cormark to a “moderate buy” rating in a report issued on Wednesday,Zacks.com reports.
A number of other research firms have also weighed in on EXE. Royal Bank of Canada raised their target price on Extendicare from C$9.50 to C$11.00 and gave the company a “sector perform” rating in a report on Thursday, November 28th. BMO Capital Markets set a C$11.00 price objective on Extendicare and gave the company a “market perform” rating in a research note on Thursday, January 30th. Finally, TD Securities lifted their price objective on shares of Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a report on Thursday, November 14th. Three research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of C$10.25.
Check Out Our Latest Stock Analysis on EXE
Extendicare Price Performance
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
- Five stocks we like better than Extendicare
- What Makes a Stock a Good Dividend Stock?
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- How to Invest in the FAANG Stocks
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.